These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 22991095)

  • 21. In vitro activities of posaconazole, ravuconazole, terbinafine, itraconazole and fluconazole against dermatophyte, yeast and non-dermatophyte species.
    Gupta AK; Kohli Y; Batra R
    Med Mycol; 2005 Mar; 43(2):179-85. PubMed ID: 15832561
    [TBL] [Abstract][Full Text] [Related]  

  • 22. In vitro growth inhibitory studies of phacidin against some dermatophytes, opportunistic and systemic fungi, and yeasts pathogenic on man.
    Sekhon AS; Funk A
    J Antimicrob Chemother; 1977 Jan; 3(1):95-100. PubMed ID: 845106
    [No Abstract]   [Full Text] [Related]  

  • 23. In vitro susceptibility of dermatomycoses agents to six antifungal drugs and evaluation by fractional inhibitory concentration index of combined effects of amorolfine and itraconazole in dermatophytes.
    Tamura T; Asahara M; Yamamoto M; Yamaura M; Matsumura M; Goto K; Rezaei-Matehkolaei A; Mirhendi H; Makimura M; Makimura K
    Microbiol Immunol; 2014 Jan; 58(1):1-8. PubMed ID: 24215461
    [TBL] [Abstract][Full Text] [Related]  

  • 24. In vitro antifungal activity of dihydroxyacetone against causative agents of dermatomycosis.
    Stopiglia CD; Vieira FJ; Mondadori AG; Oppe TP; Scroferneker ML
    Mycopathologia; 2011 Apr; 171(4):267-71. PubMed ID: 20936361
    [TBL] [Abstract][Full Text] [Related]  

  • 25. In vitro activity of voriconazole against dermatophytes, Scopulariopsis brevicaulis and other opportunistic fungi as agents of onychomycosis.
    Carrillo-Muñoz AJ; Giusiano G; Guarro J; Quindós G; Guardia C; del Valle O; Rodríguez V; Estivill D; Cárdenes CD
    Int J Antimicrob Agents; 2007 Aug; 30(2):157-61. PubMed ID: 17555945
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [In vitro antifungal activity of voriconazole against dermatophytes and superficial isolates of Scopulariopsis brevicaulis].
    Carrillo-Muñoz AJ; Cárdenes CD; Carrillo-Orive B; Rodríguez V; Del Valle O; Casals JB; Ezkurra PA; Quindós G
    Rev Iberoam Micol; 2005 Jun; 22(2):110-3. PubMed ID: 16107170
    [TBL] [Abstract][Full Text] [Related]  

  • 27. In vitro antifungal activities of Allium cepa, Allium sativum and ketoconazole against some pathogenic yeasts and dermatophytes.
    Shams-Ghahfarokhi M; Shokoohamiri MR; Amirrajab N; Moghadasi B; Ghajari A; Zeini F; Sadeghi G; Razzaghi-Abyaneh M
    Fitoterapia; 2006 Jun; 77(4):321-3. PubMed ID: 16690223
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Non-dermatophyte fungi in onychomycosis-Epidemiology and consequences for clinical practice.
    Reinel D
    Mycoses; 2021 Jul; 64(7):694-700. PubMed ID: 33539562
    [TBL] [Abstract][Full Text] [Related]  

  • 29. In vitro activity of fluconazole, itraconazole, voriconazole and terbinafine against fungi causing onychomycosis.
    Bueno JG; Martinez C; Zapata B; Sanclemente G; Gallego M; Mesa AC
    Clin Exp Dermatol; 2010 Aug; 35(6):658-63. PubMed ID: 19874354
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Potato dextrose agar antifungal susceptibility testing for yeasts and molds: evaluation of phosphate effect on antifungal activity of CMT-3.
    Liu Y; Tortora G; Ryan ME; Lee HM; Golub LM
    Antimicrob Agents Chemother; 2002 May; 46(5):1455-61. PubMed ID: 11959582
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Synthesis of isosteric triterpenoid derivatives and antifungal activity.
    Innocente A; Casanova BB; Klein F; Lana AD; Pereira D; Muniz MN; Sonnet P; Gosmann G; Fuentefria AM; Gnoatto SC
    Chem Biol Drug Des; 2014 Mar; 83(3):344-9. PubMed ID: 24138556
    [TBL] [Abstract][Full Text] [Related]  

  • 32. In vitro activity of Phytolacca dodecandra (Endod) against dermatophytes.
    Woldeamanuel Y; Abate G; Chryssanthou E
    Ethiop Med J; 2005 Jan; 43(1):31-4. PubMed ID: 16370528
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Activities of antifungal agents against yeasts and filamentous fungi: assessment according to the methodology of the European Committee on Antimicrobial Susceptibility Testing.
    Lass-Flörl C; Mayr A; Perkhofer S; Hinterberger G; Hausdorfer J; Speth C; Fille M
    Antimicrob Agents Chemother; 2008 Oct; 52(10):3637-41. PubMed ID: 18694949
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Onychomycosis in Hong Kong.
    Kam KM; Au WF; Wong PY; Cheung MM
    Int J Dermatol; 1997 Oct; 36(10):757-61. PubMed ID: 9372350
    [TBL] [Abstract][Full Text] [Related]  

  • 35. In vitro antifungal evaluation and studies on the mode of action of xanthoxyline derivatives.
    Pinheiro TR; Yunes RA; López SN; Santecchia CB; Zacchino SA; Cechinel Filho V
    Arzneimittelforschung; 1999 Dec; 49(12):1039-43. PubMed ID: 10635452
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antifungal activity of essential oil from fruits of Indian Cuminum cyminum.
    Romagnoli C; Andreotti E; Maietti S; Mahendra R; Mares D
    Pharm Biol; 2010 Jul; 48(7):834-8. PubMed ID: 20645785
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Isolation of dermatophytes (and other fungi) from human nail and skin dust produced by podiatric medical treatments in Australia.
    Hainsworth S; Hamblin JF; Vanniasinkam T
    J Am Podiatr Med Assoc; 2015 Mar; 105(2):111-20. PubMed ID: 25815649
    [TBL] [Abstract][Full Text] [Related]  

  • 38. IN VITRO ANTIFUNGAL ACTIVITY OF 2,4-DIHYDROXY-N-(3-THIOXO-3H- 1,2,4-DITHIAZOL-5-YL)BENZENECARBOTHIOAMIDE.
    Lukaszuk C; Krajewska-Kulak E; Niewiadomy A; Szynaka B
    Acta Pol Pharm; 2016 Nov; 73(6):1511-1519. PubMed ID: 29634105
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [In vitro action of a new antifungal agent, naftifine, on dermatophytes].
    Regli P; Ferrari H; Buffard Y; Goudard M; Gallucci V
    Pathol Biol (Paris); 1985 Jun; 33(5 Pt 2):614-7. PubMed ID: 3911160
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A U.S. epidemiologic survey of superficial fungal diseases.
    Kemna ME; Elewski BE
    J Am Acad Dermatol; 1996 Oct; 35(4):539-42. PubMed ID: 8859279
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.